Testicular cancer, with a high 5-year survival rate, poses significant challenges due to its treatment's impact on survivors’ quality of life. Researcher João Lobo is advancing precision diagnostics to enhance patient care. Current diagnosis lacks non-invasive methods, relying on imaging and surgical biopsies, which can lead to unnecessary surgeries. Developments like the microRNA-371∼373 test show promise for accurate diagnosis and monitoring while aiming to standardize protocols for better clinical adoption. Addressing limitations in current markers and focusing on personalized patient care remains pivotal.
Newsletters
Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.